Literature DB >> 3304960

Various administration forms of nitrates and their possibilities.

U E Jonsson.   

Abstract

This article reviews the development and pharmacokinetics of a number of new dosage formulations (e.g. transdermal patches and buccal tablets) and new active substances (e.g. isosorbide 5-mononitrate) which have recently been introduced to overcome some of the problems inherent in conventional formulations of organic nitrates.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3304960     DOI: 10.2165/00003495-198700334-00006

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  15 in total

1.  Relative bioavailability of a new transdermal nitroglycerin delivery system.

Authors:  P K Noonan; M A Gonzalez; D Ruggirello; J Tomlinson; E Babcock-Atkinson; M Ray; A Golub; A Cohen
Journal:  J Pharm Sci       Date:  1986-07       Impact factor: 3.534

2.  The controversy over transdermal nitroglycerin: an update.

Authors:  B Charash; S S Scheidt
Journal:  Am Heart J       Date:  1986-07       Impact factor: 4.749

3.  Nitroglycerin lingual spray: clinical efficacy and dose-response relation.

Authors:  J O Parker; K A Vankoughnett; B Farrell
Journal:  Am J Cardiol       Date:  1986-01-01       Impact factor: 2.778

4.  Three times daily or 8-hourly.

Authors:  R Nigam; B J Loveday; S L Grainger; D G Maxton
Journal:  J R Soc Med       Date:  1986-01       Impact factor: 5.344

5.  Studies on a sustained release principle based on an inert plastic matrix.

Authors:  J Sjögren
Journal:  Acta Pharm Suec       Date:  1971-06

6.  Evaluation of two nitroglycerin dosage forms: a metered spray and a soft gelatin capsule.

Authors:  R Erb; W Stoltman
Journal:  J Pharmacokinet Biopharm       Date:  1983-12

7.  The in vitro development of extended-release solid oral dosage forms.

Authors:  L J Leeson; D Adair; J Clevenger; N Chiang
Journal:  J Pharmacokinet Biopharm       Date:  1985-10

Review 8.  Nitrate delivery systems in perspective. A decade of progress.

Authors:  J Abrams
Journal:  Am J Med       Date:  1984-06-22       Impact factor: 4.965

Review 9.  Nitrate formulations and drug delivery systems--an overview.

Authors:  H L Fung
Journal:  Z Kardiol       Date:  1985

10.  [Serum concentration of glyceryl trinitrate (GTN) in transdermal application of GTN dressings of various origins].

Authors:  R Heidemann; G Menke; H Letzel; N Rietbrock
Journal:  Dtsch Med Wochenschr       Date:  1985-10-11       Impact factor: 0.628

View more
  5 in total

Review 1.  Development of long-acting nitrate delivery systems.

Authors:  U E Jonsson
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

Review 2.  Isosorbide 5-mononitrate: a review of a sustained-release formulation (Imdur) in stable angina pectoris.

Authors:  N S Gunasekara; S Noble
Journal:  Drugs       Date:  1999-02       Impact factor: 9.546

3.  Dose-dependent headache response and dilatation of limb and extracranial arteries after three doses of 5-isosorbide-mononitrate.

Authors:  H K Iversen; T H Nielsen; K Garre; P Tfelt-Hansen; J Olesen
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

4.  The plasma concentrations of isosorbide 5-mononitrate (5-ISMN) administered in an extended-release form to patients with acute myocardial infarction.

Authors:  W McClennen; B Hornestam; U E Jonsson; P Held
Journal:  Br J Clin Pharmacol       Date:  1995-06       Impact factor: 4.335

Review 5.  Clinical experience with Imdur in angina pectoris. A review.

Authors:  G Nyberg
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.